Fabricator: Zyvex Pharmaceuticals
Unit: x1 100 tabs
Strength: 25 mg/tab
If your order hasn’t arrived within 35 days after shipping, we’ll resend it for free.
Ostarine is the SARM with the longest paper trail. Enobosarm, as the research literature calls it, has been trialled for cancer cachexia, osteoporosis and muscle wasting in older adults, and those trials are the reason its dosing and side effect profile are better understood than most compounds on this shelf.
The Zyvex pack is a foil blister of tablets inside a printed box. The realistic expectation is modest: a little lean tissue, better joints, and the ability to hold muscle in a deficit without the hormonal upheaval a steroid brings.
Enobosarm binds the androgen receptor with tissue selectivity, favouring muscle and bone over prostate and skin relative to testosterone, and it is neither aromatised nor 5-alpha reduced. The elimination half-life is roughly twenty-four hours, so once-daily dosing holds a level.
The part that gets underplayed is how much of your own production goes quiet. At 10 to 15 mg most users lose a little total testosterone; at 25 mg the drop is dependable enough that recovery turns into a plan rather than a hope. The compound is not methylated, so hepatic stress is not the headline risk the way it is for an oral steroid.
The active ingredient is MK 2866 at the per-tablet strength printed on the Zyvex blister. The tablet base uses standard binders, filler, disintegrant and lubricant, and the complete excipient panel is on the box. No stimulant, no aromatase inhibitor and no testosterone is included.
One tablet a day, at a consistent time, with or without food. An eight-week block is standard. Because the half-life is close to a full day, splitting the dose adds nothing; the clock and consistency matter more than the meal.
Bloodwork at week four is what separates a sensible run from a guess. If total testosterone has fallen noticeably by then, the sensible response is to finish at eight weeks and run a short recovery rather than to extend the block for another month.
Reported ranges, not a prescription:
Suppression is dose dependent and usually mild at the bottom of the range. At 25 mg, total testosterone can drop far enough that motivation is gone for a few weeks after the block ends. Headache and sleep changes appear in a minority of users.
Nothing here is methylated, so hepatic enzymes normally stay unremarkable, with the occasional exception. Lipids shift a little in some users. Gynaecomastia does not belong to this compound.
Baseline bloodwork and a week-four panel: total testosterone, LH, lipids and liver enzymes. If testosterone has not recovered a month after the last tablet, a short SERM course is the usual next step rather than a second SARM.
Not for under-21s, anyone with a history of hormone-sensitive cancer, or anyone pregnant or nursing. Store at room temperature, dry and out of light, in the sealed blister. Sold for research use, and the laboratory testing for this range is pending rather than published.
Please log in to write Ostarine (MK 2866) review.
It helps you keep muscle while you lose fat, adds a small amount in a surplus, and makes joints feel better. It does not add dramatic size, and anyone selling it as a steroid replacement is selling something else.
For a first run, usually yes. Ten milligrams for eight weeks produces the joint and recomp effect with the least suppression, which is the point of choosing ostarine in the first place.
At 10 to 15 mg for eight weeks, recovery is usually quick and needs nothing extra. At 25 mg, plan a short SERM course and let a blood test confirm it worked.
Because tissue selectivity is relative, not absolute. At bodybuilding doses the pituitary slows LH output and total testosterone follows, even though the compound is not a steroid.
That pairing is common: ostarine for tissue and joints, MK 677 for sleep, appetite and recovery. Neither suppresses the other's mechanism.